U.S.
FDA APPROVES NEW OPIOID PAINKILLER TEN TIMES AS POWERFUL AS FENTANYL, DESPITE ADDICTION FEARS
By Hannah Preston On Saturday, November 3, 2018 - 13:27
An opioid pill, which some critics predict will cause overdose deaths, was approved by the FDA on Friday the Associated Press reported.
The pill, known as Dsuvia, is a tablet placed underneath the tongue to treat intense pain within 30 minutes. It was mainly created to be used on the battlefield or in emergency situations within hospitals, where an IV wouldn't suffice.
The drug contains sufentanil, a chemical cousin of the opioid fentanyl, which is a narcotic used during surgery and childbirth.
Critics of Dsuvia's approval say the drug would be extremely easy to manipulate. Since it is so small and concentrated, critics believe the pill will be pocketed and sold in the drug market – causing more overdose deaths.
“This is a dangerous, reckless move,” Dr. Sidney Wolfe, senior adviser of Public Citizen’s Health Research Group, told NBC News.
まずいでしょ。こんな薬💊そのうち闇か処方薬で出回る。
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action[2]), and the replacement of the phenyl ring by thiophene. Sufentanil first was synthesized at Janssen Pharmaceutica in 1974.
FDA APPROVES NEW OPIOID PAINKILLER TEN TIMES AS POWERFUL AS FENTANYL, DESPITE ADDICTION FEARS
By Hannah Preston On Saturday, November 3, 2018 - 13:27
An opioid pill, which some critics predict will cause overdose deaths, was approved by the FDA on Friday the Associated Press reported.
The pill, known as Dsuvia, is a tablet placed underneath the tongue to treat intense pain within 30 minutes. It was mainly created to be used on the battlefield or in emergency situations within hospitals, where an IV wouldn't suffice.
The drug contains sufentanil, a chemical cousin of the opioid fentanyl, which is a narcotic used during surgery and childbirth.
Critics of Dsuvia's approval say the drug would be extremely easy to manipulate. Since it is so small and concentrated, critics believe the pill will be pocketed and sold in the drug market – causing more overdose deaths.
“This is a dangerous, reckless move,” Dr. Sidney Wolfe, senior adviser of Public Citizen’s Health Research Group, told NBC News.
まずいでしょ。こんな薬💊そのうち闇か処方薬で出回る。
Sufentanil, sold under the brand names Dsuvia and Sufenta, is a synthetic opioid analgesic drug approximately 5 to 10 times more potent than its parent drug, fentanyl, and 500 times as potent as morphine. Structurally, sufentanil differs from fentanyl through the addition of a methoxymethyl group on the piperidine ring (which is believed to reduce duration of action[2]), and the replacement of the phenyl ring by thiophene. Sufentanil first was synthesized at Janssen Pharmaceutica in 1974.
